C392 (Deferasirox 180 mg)
Pill with imprint C392 is Pink, Capsule-shape and has been identified as Deferasirox 180 mg. It is supplied by Cipla USA, Inc..
Deferasirox is used in the treatment of thalassemia; iron overload; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C392
Deferasirox
- Imprint
- C392
- Strength
- 180 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Chelating agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- National Drug Code (NDC)
- 69097-0392
More about deferasirox
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: chelating agents
Consumer resources
- Patient Information
- Deferasirox (Advanced Reading)
- Deferasirox Sprinkle Granules
- Deferasirox Tablets
- Deferasirox Tablets For Oral Suspension
- Other brands
- Jadenu, Exjade, Jadenu Sprinkle
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.